Loading organizations...
Loading organizations...
Biotechnology company developing personalized cancer immunotherapies.
T-Curx has raised $20.0M across 1 funding round.
T-Curx has raised $20.0M in total across 1 funding round.
T-Curx has raised $20.0M in total across 1 funding round.
T-Curx's investors include Dr. Aristotelis Nastos, Monika Steger, i&i Biotech Fund.
T-Curx has raised $20.0M across 1 funding round. Most recently, it raised $20.0M Series A in December 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 17, 2025 | $20.0M Series A | Dr. Aristotelis Nastos | Monika Steger, i&i Biotech Fund |